Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.

Spencer CH, Rouster-Stevens K, Gewanter H, Syverson G, Modica R, Schmidt K, Emery H, Wallace C, Grevich S, Nanda K, Zhao YD, Shenoi S, Tarvin S, Hong S, Lindsley C, Weiss JE, Passo M, Ede K, Brown A, Ardalan K, Bernal W, Stoll ML, Lang B, Carrasco R, Agaiar C, Feller L, Bukulmez H, Vehe R, Kim H, Schmeling H, Gerstbacher D, Hoeltzel M, Eberhard B, Sundel R, Kim S, Huber AM, Patwardhan A; Pediatric Rheumatologist Collaborators.

Pediatr Rheumatol Online J. 2017 Jun 13;15(1):50. doi: 10.1186/s12969-017-0174-0.

2.

Adaptive designs for comparative effectiveness research trials.

Kairalla JA, Coffey CS, Thomann MA, Shorr RI, Muller KE.

Clin Res Regul Aff. 2015;32(1):36-44. Epub 2014 Nov 13.

3.

Comparative effectiveness research and its utility in In-clinic practice.

Dang A, Kaur K.

Perspect Clin Res. 2016 Jan-Mar;7(1):9-14. doi: 10.4103/2229-3485.173780. Review.

4.

Securing reimbursement for patient centered haemophilia care: major collaborative efforts are needed.

Berger KC, Feldman BM, Wasserman J, Schramm W, Blanchette V, Fischer K; Outcome Measures Expert Working Group of the International Prophylaxis Study Group (IPSG).

Haematologica. 2016 Mar;101(3):266-8. doi: 10.3324/haematol.2015.139931. No abstract available.

5.
6.

Project Stakeholder Management in the Clinical Research Environment: How to Do it Right.

Pandi-Perumal SR, Akhter S, Zizi F, Jean-Louis G, Ramasubramanian C, Edward Freeman R, Narasimhan M.

Front Psychiatry. 2015 May 18;6:71. doi: 10.3389/fpsyt.2015.00071. eCollection 2015. Review.

7.

Added value of cost-utility analysis in simple diagnostic studies of accuracy: (18)F-fluoromethylcholine PET/CT in prostate cancer staging.

Gerke O, Poulsen MH, Høilund-Carlsen PF.

Am J Nucl Med Mol Imaging. 2015 Jan 15;5(2):183-94. eCollection 2015.

8.

Advances in Patient-Reported Outcomes: The NIH PROMIS(®) Measures.

Broderick JE, DeWitt EM, Rothrock N, Crane PK, Forrest CB.

EGEMS (Wash DC). 2013 Aug 2;1(1):1015. doi: 10.13063/2327-9214.1015. eCollection 2013.

9.

Building for tomorrow today: opportunities and directions in radiology resident research.

Yu JP, Kansagra AP, Thaker A, Colucci A, Sherry SJ, Subramaniam RM.

Acad Radiol. 2015 Jan;22(1):50-7. doi: 10.1016/j.acra.2014.08.012. Epub 2014 Oct 14. Review.

10.

Towards Building a Bridge between Community Engagement in Research (CEnR) and Comparative Effectiveness Research (CER).

Ahmed SM, Nelson D, Kissack A, Franco Z, Whittle J, Kotchen T, Meurer JR, Morzinski J, Brandenburg T.

Clin Transl Sci. 2015 Apr;8(2):160-5. doi: 10.1111/cts.12236. Epub 2014 Dec 2.

11.

What can comparative effectiveness research contribute to integrative health in international perspective?

Witt CM, Rafferty Withers S, Grant S, Lauer MS, Tunis S, Berman BM.

J Altern Complement Med. 2014 Nov;20(11):874-80. doi: 10.1089/acm.2014.0073. Epub 2014 Nov 5.

12.

IMPACT--Integrative Medicine PrimAry Care Trial: protocol for a comparative effectiveness study of the clinical and cost outcomes of an integrative primary care clinic model.

Herman PM, Dodds SE, Logue MD, Abraham I, Rehfeld RA, Grizzle AJ, Urbine TF, Horwitz R, Crocker RL, Maizes VH.

BMC Complement Altern Med. 2014 Apr 7;14:132. doi: 10.1186/1472-6882-14-132.

13.

Improving efficiency and reducing costs: Design of an adaptive, seamless, and enriched pragmatic efficacy trial of an online asthma management program.

Lu M, Ownby DR, Zoratti E, Roblin D, Johnson D, Johnson CC, Joseph CL.

Contemp Clin Trials. 2014 May;38(1):19-27. doi: 10.1016/j.cct.2014.02.008. Epub 2014 Mar 6.

14.

Evaluating treatment effectiveness under model misspecification: A comparison of targeted maximum likelihood estimation with bias-corrected matching.

Kreif N, Gruber S, Radice R, Grieve R, Sekhon JS.

Stat Methods Med Res. 2016 Oct;25(5):2315-2336. Epub 2014 Feb 12.

15.

Are the effects of homeopathy attributable to a statistical artefact? A reanalysis of an observational study.

Lüdtke R, Willich SN, Ostermann T.

Evid Based Complement Alternat Med. 2013;2013:612890. doi: 10.1155/2013/612890. Epub 2013 Dec 15.

16.

Outcomes research in childhood autoimmune diseases.

DeWitt EM.

Rheum Dis Clin North Am. 2013 Nov;39(4):921-33. doi: 10.1016/j.rdc.2013.07.004. Review.

17.

A model for incorporating patient and stakeholder voices in a learning health care network: Washington State's Comparative Effectiveness Research Translation Network.

Devine EB, Alfonso-Cristancho R, Devlin A, Edwards TC, Farrokhi ET, Kessler L, Lavallee DC, Patrick DL, Sullivan SD, Tarczy-Hornoch P, Yanez ND, Flum DR; CERTAIN Collaborative.

J Clin Epidemiol. 2013 Aug;66(8 Suppl):S122-9. doi: 10.1016/j.jclinepi.2013.04.007.

18.

Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects.

Simonds NI, Khoury MJ, Schully SD, Armstrong K, Cohn WF, Fenstermacher DA, Ginsburg GS, Goddard KA, Knaus WA, Lyman GH, Ramsey SD, Xu J, Freedman AN.

J Natl Cancer Inst. 2013 Jul 3;105(13):929-36. doi: 10.1093/jnci/djt108. Epub 2013 May 9.

19.
20.

Building a strategic framework for comparative effectiveness research in complementary and integrative medicine.

Witt CM, Chesney M, Gliklich R, Green L, Lewith G, Luce B, McCaffrey A, Rafferty Withers S, Sox HC, Tunis S, Berman BM.

Evid Based Complement Alternat Med. 2012;2012:531096. doi: 10.1155/2012/531096. Epub 2012 Dec 26.

Supplemental Content

Support Center